Stockscreener 앱 받기
0.00
100.00%
-0.1426
전일 마감가:
$0.1426
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$7.90M
수익:
$3.10M
순이익/손실:
$-97.43M
주가수익비율:
0.00
EPS:
-1.8
순현금흐름:
$-94.38M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$3.00
Omega Therapeutics Inc Stock (OMGA) Company Profile
명칭
Omega Therapeutics Inc
전화
(617) 949-4360
주소
140 FIRST STREET, SUITE 501, CAMBRIDGE
OMGA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OMGA
Omega Therapeutics Inc
|
0.00 | 7.90M | 3.10M | -97.43M | -94.38M | -1.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
503.50 | 126.09B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
568.91 | 64.01B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
629.51 | 36.63B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
257.19 | 30.64B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
249.77 | 27.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Omega Therapeutics Inc Stock (OMGA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-15 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2024-06-18 | 개시 | Raymond James | Outperform |
| 2023-05-25 | 재개 | Jefferies | Buy |
| 2022-12-08 | 개시 | H.C. Wainwright | Buy |
| 2022-09-23 | 개시 | Chardan Capital Markets | Buy |
Omega Therapeutics Inc 주식(OMGA)의 최신 뉴스
Omega Therapeutics (NASDAQ:OMGA) Trading Down 21.8% – Time to Sell? - Defense World
Biotech Firm Omega Therapeutics OK'd For $14M Ch. 11 Sale - Law360
Layoff Tracker: Tempest Axes 80% of Workforce - BioSpace
Recursion Pharmaceuticals (NASDAQ:RXRX) & Omega Therapeutics (NASDAQ:OMGA) Critical Analysis - Defense World
OMEGA THERAPEUTICS INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus
Omega Therapeutics (OMGA) Projected to Post Earnings on Thursday - The AM Reporter
Omega Therapeutics (OMGA) to Release Quarterly Earnings on Thursday - Defense World
Flagship's Empress lays off 53% of staffers in push to get science to clinic - Fierce Biotech
Omega Therapeutics secures $9.8M in DIP financing - MSN
Programmable mRNA therapeutics for controlled epigenomic modulation of single and multiplexed gene expression in diverse diseases - Nature
Lila Sciences raises $200M to accelerate autonomous scientific research - SiliconANGLE
HilleVax (NASDAQ:HLVX) & Omega Therapeutics (NASDAQ:OMGA) Critical Survey - Defense World
Struggling healthcare firm files for Chapter 11 bankruptcy - TheStreet
Petri Dish: Bankrupt Flagship firm sells assets; Nimbus hits milestone - The Business Journals
OMEGA THERAPEUTICS INC Revenue Breakdown – OTC:OMGAQ - TradingView
Two new option listings and eighteen option delistings on February 25th - TipRanks
Omega Therapeutics to sell assets amid Nasdaq delisting By Investing.com - Investing.com India
Omega Therapeutics to sell assets amid Nasdaq delisting - Investing.com
Intrommune Therapeutics Announces Publication of OMEGA Study in Peanut Allergic Adults in Annals of Allergy, Asthma & Immunology - GlobeNewswire
Volcon, Inc. and GlucoTrack, Inc. See Massive Gains, While Omega Therapeutics and Universe Pharmaceuticals Struggle - HPBL
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Omega Therapeutics Inc (OMGA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.78%
2.03%
자본화:
|
볼륨(24시간):